Non-inclusion complexes between riboflavin and cyclodextrins


Autoria(s): de Jesus, Marcelo Bispo; Fraceto, Leonardo Fernandes; Florencia Martini, Maria; Pickholz, Monica; Ferreira, Carmen Verissima; de Paula, Eneida
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

25/10/2016

20/05/2014

25/10/2016

01/06/2012

Resumo

Objectives To investigate the molecular interaction between beta-cyclodextrin (beta CD) or hydroxypropyl-beta-cyclodextrin (HP beta CD) and riboflavin (RF), and to test the anticancer potential of these formulations. Methods The physicochemical characterization of the association between RF and CDs was performed by UV-vis absorption, fluorescence, differential scanning calorimetry and NMR techniques. Molecular dynamics simulation was used to shed light on the mechanism of interaction of RF and CDs. Additionally, in-vitro cell culture tests were performed to evaluate the cytotoxicity of the RFCD complexes against prostate cancer cells. Key findings Neither beta CD nor HP beta CD led to substantial changes in the physicochemical properties of RF (with the exception of solubility). Additionally, rotating frame Overhauser effect spectroscopy experiments detected no spatial correlations between hydrogens from the internal cavity of CDs and RF, while molecular dynamics simulations revealed out-of-ring RFCD interactions. Notwithstanding, both RF beta CD and RFHP beta CD complexes were cytotoxic to PC3 prostate cancer cells. Conclusions The interaction between RF and either beta CD or HP beta CD, at low concentrations, seems to be made through hydrogen bonding between the flavonoid and the external rim of both CDs. Regardless of the mechanism of complexation, our findings indicate that RFCD complexes significantly increase RF solubility and potentiate its antitumour effect.

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Identificador

Journal of Pharmacy and Pharmacology. Malden: Wiley-blackwell, v. 64, n. 6, p. 832-842, 2012.

0022-3573

http://hdl.handle.net/11449/177

http://acervodigital.unesp.br/handle/11449/177

10.1111/j.2042-7158.2012.01492.x

WOS:000303858200008

http://dx.doi.org/10.1111/j.2042-7158.2012.01492.x

Idioma(s)

eng

Publicador

Wiley-Blackwell

Relação

Journal of Pharmacy and Pharmacology

Direitos

info:eu-repo/semantics/closedAccess

Palavras-Chave #cyclodextrin #NMR #non-inclusion complex #prostate cancer #riboflavin
Tipo

outro